297 related articles for article (PubMed ID: 28237722)
1. Dapper1 attenuates hepatic gluconeogenesis and lipogenesis by activating PI3K/Akt signaling.
Kuang JR; Zhang ZH; Leng WL; Lei XT; Liang ZW
Mol Cell Endocrinol; 2017 May; 447():106-115. PubMed ID: 28237722
[TBL] [Abstract][Full Text] [Related]
2. FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis.
Wang C; Chi Y; Li J; Miao Y; Li S; Su W; Jia S; Chen Z; Du S; Zhang X; Zhou Y; Wu W; Zhu M; Wang Z; Yang H; Xu G; Wang S; Yang J; Guan Y
Hepatology; 2014 May; 59(5):1779-90. PubMed ID: 24806753
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis.
Wang J; Yang W; Chen Z; Chen J; Meng Y; Feng B; Sun L; Dou L; Li J; Cui Q; Yang J
Diabetes; 2018 Apr; 67(4):581-593. PubMed ID: 29382663
[TBL] [Abstract][Full Text] [Related]
4. Hepatic overexpression of ATP synthase β subunit activates PI3K/Akt pathway to ameliorate hyperglycemia of diabetic mice.
Wang C; Chen Z; Li S; Zhang Y; Jia S; Li J; Chi Y; Miao Y; Guan Y; Yang J
Diabetes; 2014 Mar; 63(3):947-59. PubMed ID: 24296716
[TBL] [Abstract][Full Text] [Related]
5. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
6. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J
Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
[TBL] [Abstract][Full Text] [Related]
8. DMT efficiently inhibits hepatic gluconeogenesis by regulating the Gαq signaling pathway.
Zhou TT; Ma F; Shi XF; Xu X; Du T; Guo XD; Wang GH; Yu L; Rukachaisirikul V; Hu LH; Chen J; Shen X
J Mol Endocrinol; 2017 Aug; 59(2):151-169. PubMed ID: 28637808
[TBL] [Abstract][Full Text] [Related]
9. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice.
Zhao Z; Deng X; Jia J; Zhao L; Wang C; Cai Z; Guo C; Yang L; Wang D; Ma S; Deng J; Li H; Zhou L; Tu Z; Yuan G
Metabolism; 2022 Jan; 126():154921. PubMed ID: 34715116
[TBL] [Abstract][Full Text] [Related]
11. d- chiro-Inositol Ameliorates High Fat Diet-Induced Hepatic Steatosis and Insulin Resistance via PKCε-PI3K/AKT Pathway.
Cheng F; Han L; Xiao Y; Pan C; Li Y; Ge X; Zhang Y; Yan S; Wang M
J Agric Food Chem; 2019 May; 67(21):5957-5967. PubMed ID: 31066268
[TBL] [Abstract][Full Text] [Related]
12. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
13. Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
Liao YJ; Lee TS; Twu YC; Hsu SM; Yang CP; Wang CK; Liang YC; Chen YA
J Biomed Sci; 2016 Oct; 23(1):69. PubMed ID: 27716281
[TBL] [Abstract][Full Text] [Related]
14. APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice.
Cheng KK; Iglesias MA; Lam KS; Wang Y; Sweeney G; Zhu W; Vanhoutte PM; Kraegen EW; Xu A
Cell Metab; 2009 May; 9(5):417-27. PubMed ID: 19416712
[TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway.
Liu Y; Deng J; Fan D
Food Funct; 2019 May; 10(5):2538-2551. PubMed ID: 30993294
[TBL] [Abstract][Full Text] [Related]
16. Glutamine administration promotes hepatic glucose homeostasis through regulating the PI3K/Akt pathway in high-fat diet-induced obese mice with limb ischemia.
Pitaloka DMI; Ko CH; Lin MT; Yeh SL; Yeh CL
Nutr Res; 2019 Aug; 68():45-53. PubMed ID: 31419579
[TBL] [Abstract][Full Text] [Related]
17. Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway.
Yan J; Wang C; Jin Y; Meng Q; Liu Q; Liu Z; Liu K; Sun H
Pharmacol Res; 2018 Apr; 130():466-480. PubMed ID: 29284152
[TBL] [Abstract][Full Text] [Related]
18. Long-term co-administration of sodium nitrite and sodium hydrosulfide inhibits hepatic gluconeogenesis in male type 2 diabetic rats: Role of PI3K-Akt-eNOS pathway.
Jeddi S; Gheibi S; Carlström M; Kashfi K; Ghasemi A
Life Sci; 2021 Jan; 265():118770. PubMed ID: 33212150
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus.
Chen SH; Liu XN; Peng Y
J Cell Mol Med; 2019 Sep; 23(9):5895-5906. PubMed ID: 31287224
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis
Sun X; Cao Z; Ma Y; Shao Y; Zhang J; Yuan G; Guo X
Food Funct; 2021 Feb; 12(3):1207-1218. PubMed ID: 33432947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]